ACTB and Alzheimer disease: The prediction model allows for the prioritization of ACTB for individuals with the common comorbidities of sensorineural hearing loss and arthropathy/arthritis with risk of AD (where the SPOKE informed connection linking sensorineural hearing loss, arthropathy, arthritis and AD all together through ACTB has not been previously implicated in literature).